Top Markets
#1 StakeStone StakeStone +9.57%
#2 ZetaChain ZetaChain +7.41%
#3 Janction Janction +6.16%
#4 WAX WAX +5.34%
#5 Lombard Lombard +5.23%
#6 0G 0G +4.93%
#7 Hegic Hegic +4.79%
#8 WAR WAR +4.34%
#9 Grass Grass +4.12%
#10 Infinity Ground Infinity Ground +3.60%
Coin of the day
StakeStone StakeStone
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Sanofi Sanofi

Sanofi

SNY
Rang in Aktien #179
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Aktienkurs
$44.60
Marktkapitalisierung
$108.62B
Veränderung (1 Tag)
-1.63%
Veränderung (1 Jahr)
-21.62%
Land
FR
Handel Sanofi (SNY)

Kategorie

Healthcare
P/S-Verhältnis für Sanofi (SNY)
P/S-Verhältnis zum March 2026 TTM: 1.58
Laut den neuesten Finanzberichten und dem Aktienkurs von Sanofi beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 1.58. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 2.65.
P/S-Verlauf für Sanofi von 2000 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 1.58 -31.45%
2025 2.31 -12.64%
2024 2.65 8.53%
2023 2.44 -1.50%
2022 2.48 -12.51%
2021 2.83 7.27%
2020 2.64 -11.31%
2019 2.98 12.55%
2018 2.64 6.21%
2017 2.49 -12.68%
2016 2.85 -3.17%
2015 2.95 -5.34%
2014 3.11 -4.59%
2013 3.26 24.47%
2012 2.62 22.45%
2011 2.14 9.73%
2010 1.95 -16.66%
2009 2.34 13.41%
2008 2.06 -28.87%
2007 2.90 -10.07%
2006 3.22 -7.11%
2005 3.47 -2.51%
2004 3.56 -31.81%
2003 5.22 -8.16%
2002 5.69 -39.51%
2001 9.40 8.55%
2000 8.66 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
14.26 800.32%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
4.96 213.28%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.18 290.20%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.35 301.05%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
5.18 226.89%
CH